|
|
Post by dpca10 on Mar 18, 2016 11:39:55 GMT -5
I have a different theory. For the last year Matt has tried to convince the world that this is still a biotech startup with all this future potential. I think they have successfully convinced people that we have enough money and options to not go into bankruptcy and now have hit the reset button on expectations. They've successfully decoupled share price from Arezza sales. The MNKD 2.0 campaign was a good idea, make MNKD a longer term speculative stock again and put the immediate real world metrics on the back burner for a year or two. I used to bet on companies earnings projections and guess right yet watch the share price fall. Selling the long term fantasy is where the money's at.
|
|
|
|
Post by mnkdfann on Mar 18, 2016 11:51:13 GMT -5
Another possible reason, much money has come out of VRX and CXRX in the last week and it has to go somewhere. I imagine big investors already have full positions in the large drug / pharma / and related companies, so at least some of the money coming out is being distributed among the smaller ones. I've noticed another small drug company I watch (ONCY) is also up over 50% this week on no news, for instance.
|
|
|
|
Post by mindovermatter on Mar 18, 2016 13:16:18 GMT -5
Another possible reason, much money has come out of VRX and CXRX in the last week and it has to go somewhere. I imagine big investors already have full positions in the large drug / pharma / and related companies, so at least some of the money coming out is being distributed among the smaller ones. I've noticed another small drug company I watch (ONCY) is also up over 50% this week on no news, for instance. Anyone's guess but it appears that someone knows something and is either getting out of their short position or someone is very eager to pick up shares knowing that something cosmic is about to happen. It would be nice for once to get significantly great news that proves that Mannkind is on solid foundation for once. |
|
|
|
Post by chuck on Mar 18, 2016 15:12:07 GMT -5
I would say none of the above, rather more to do with options expiry date today. We'll see over the coming days/weeks.
|
|
|
|
Post by cretin11 on Mar 18, 2016 18:50:12 GMT -5
I would say none of the above, rather more to do with options expiry date today. We'll see over the coming days/weeks. That's an interesting thought. But if so, then why didn't the share price get pinned to 1.50 or 1.00, or can you expound on why options expiry would result in such a large move upwards? |
|
|
|
Post by trenddiver on Mar 18, 2016 20:27:14 GMT -5
Thought I woul repost my investment thesis made on February 24, when I advised the board that the technical indicators had turned bullish. At that time the SP was less than a $1. I think what you are seeing here is this thesis playing out. Trend "All you have to do is watch the price action to know that the shorts are in control. That doesn't mean that technical analysis isnt reflecting bullish indicators. My current investment thesis is that these strong bullish indicators could draw interest in the stock from those who follow technical analysis which could create share price momentum drawing in momentum players, which would put a lot of pressure on the shorts, which could create additional bias to the upside. I admit it's a little contrarian considering what's happening on the business side. Also, not too much downside. Risk is only a $1 a share vs. large upside if things turnaround. " Trend Read more: mnkd.proboards.com/user/126/recent#ixzz43J8DJZOO |
|
|
|
Post by BlueCat on Mar 18, 2016 21:06:30 GMT -5
Thought I woul repost my investment thesis made on February 24, when I advised the board that the technical indicators had turned bullish. At that time the SP was less than a $1. I think what you are seeing here is this thesis playing out. Trend "All you have to do is watch the price action to know that the shorts are in control. That doesn't mean that technical analysis isnt reflecting bullish indicators. My current investment thesis is that these strong bullish indicators could draw interest in the stock from those who follow technical analysis which could create share price momentum drawing in momentum players, which would put a lot of pressure on the shorts, which could create additional bias to the upside. I admit it's a little contrarian considering what's happening on the business side. Also, not too much downside. Risk is only a $1 a share vs. large upside if things turnaround. " Trend Read more: mnkd.proboards.com/user/126/recent#ixzz43J8DJZOOThere is to tag on this, the possibility of an investor entering for a larger share. There's been some thinking of Old Mann leaving shares or what - which was admittedly, unlikely. However, that's not to say that the Foundation may not have other interests, and choose to invest more here to increase stake? |
|
|
|
Post by cretin11 on Mar 18, 2016 22:37:32 GMT -5
Thought I woul repost my investment thesis made on February 24, when I advised the board that the technical indicators had turned bullish. At that time the SP was less than a $1. I think what you are seeing here is this thesis playing out. Trend "All you have to do is watch the price action to know that the shorts are in control. That doesn't mean that technical analysis isnt reflecting bullish indicators. My current investment thesis is that these strong bullish indicators could draw interest in the stock from those who follow technical analysis which could create share price momentum drawing in momentum players, which would put a lot of pressure on the shorts, which could create additional bias to the upside. I admit it's a little contrarian considering what's happening on the business side. Also, not too much downside. Risk is only a $1 a share vs. large upside if things turnaround. " Trend Read more: mnkd.proboards.com/user/126/recent#ixzz43J8DJZOOtrend you nailed it. Wondering what your view is of the current situation and where it goes from here? |
|
|
|
Post by kc on Mar 18, 2016 22:41:37 GMT -5
Thought I woul repost my investment thesis made on February 24, when I advised the board that the technical indicators had turned bullish. At that time the SP was less than a $1. I think what you are seeing here is this thesis playing out. Trend "All you have to do is watch the price action to know that the shorts are in control. That doesn't mean that technical analysis isnt reflecting bullish indicators. My current investment thesis is that these strong bullish indicators could draw interest in the stock from those who follow technical analysis which could create share price momentum drawing in momentum players, which would put a lot of pressure on the shorts, which could create additional bias to the upside. I admit it's a little contrarian considering what's happening on the business side. Also, not too much downside. Risk is only a $1 a share vs. large upside if things turnaround. " Trend Read more: mnkd.proboards.com/user/126/recent#ixzz43J8DJZOOThere is to tag on this, the possibility of an investor entering for a larger share. There's been some thinking of Old Mann leaving shares or what - which was admittedly, unlikely. However, that's not to say that the Foundation may not have other interests, and choose to invest more here to increase stake? I have always been surprised that we have not found that activist investor who would drive the price up. There has to be somebody out there who knows what the value of this company is once the product is actively marketed. With the wild share pricing activities this week perhaps set activist investor will be showing his face very shortly. |
|
|
|
Post by mnkdfann on Mar 18, 2016 23:17:05 GMT -5
I would say none of the above, rather more to do with options expiry date today. We'll see over the coming days/weeks. That's an interesting thought. But if so, then why didn't the share price get pinned to 1.50 or 1.00, or can you expound on why options expiry would result in such a large move upwards? One would have to analyze the number of option contracts outstanding (and perhaps the volatility associated with the prices) to figure out why it would tend to pin at one price and not another. |
|
|
|
Post by vestful on Mar 19, 2016 1:26:34 GMT -5
Something about Matt's confidence over the last 3 investor communications feels odd. He seems like there is a resilient factor that goes beyond what we currently know. My guess, they've been working hard since the summer of 15' on a plan of action after they were certain sny was sandbagging. Hakan was probably in on the correction plan but mnkd needed a fall guy and that's what goes with the position(plus he was lame). Then keep him quiet with $. Add in the significance of the passing of Al. The mentor of many more individuals than get mentioned in articles. How many people did he touch in his lifetime? Provides a lot will and determination to people whether investor or employee,etc. Wouldn't bet against it. Also, Matt left some optimism on the table for the short side to chew on.
|
|
|
|
Post by kuka on Mar 19, 2016 1:50:41 GMT -5
the heavy volume and 13 mil buy at the close leads me to believe that AMGEN or someone else just bought a 5% stake in MNKD....
|
|
|
|
Post by rockstarrick on Mar 19, 2016 5:38:18 GMT -5
Here is another guess as to why MNKD is going up. Men like their prostates, right where they are. (I am so inappropriate) Sorry, but I don't get it. You need to go spend 1 week on YMB, then report back !! |
|
|
|
Post by robsacher on Mar 19, 2016 6:11:42 GMT -5
My feeling, in addition to the well stated other possibilities, is that there are powerful interests behind the massive shorting of MannKind aligned with MannKind's competitors. Now that Sanofi has announced their exit from the MannKind partnership, MannKind's competitors no longer have much of a concern for Afrezza's competitive potential. The powerful interests who are working on behalf of MannKind's competitors are being released from their positions and as such they are now returning MannKind's shorted shares.
If the day comes when Afrezza appears to be or demonstrate the possibility of a serious market threat to MannKind's competitors, I think we'll see the massive shorting return.
|
|
|
|
Post by peppy on Mar 19, 2016 6:32:58 GMT -5
My feeling, in addition to the well stated other possibilities, is that there are powerful interests behind the massive shorting of MannKind aligned with MannKind's competitors. Now that Sanofi has announced their exit from the MannKind partnership, MannKind's competitors no longer have much of a concern for Afrezza's competitive potential. The powerful interests who are working on behalf of MannKind's competitors are being released from their positions and as such they are now returning MannKind's shorted shares. If the day comes when Afrezza appears to be or demonstrate the possibility of a serious market threat to MannKind's competitors, I think we'll see the massive shorting return. I read this as, Sanofi, Pfizer, Lilly, GSK. MRK and, Johnson and Johnson are covering. I have dyslexia and may be suffering a brain injury. 
|
|
